A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients with Non–Small-Cell Lung Cancer

Podobne zapisy

• Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor 
Receptor Mutations in Non-small Cell Lung Cancer
  od: Xue YANG, i wsp.
  Wydane: (2015-08-01)
• Epidermal Growth Factor Receptor Mutations and Radiotherapy 
in Non-small Cell Lung Cancer
  od: Xing ZHONG, i wsp.
  Wydane: (2013-03-01)
• Optimal Therapeutic Strategy for Non-small Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor
  od: Zhong SHI, i wsp.
  Wydane: (2015-02-01)
• Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non–small Cell Lung Cancer Therapy
  od: Qinghua ZHOU, i wsp.
  Wydane: (2009-12-01)
• Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor 
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
  od: Yuan LI, i wsp.
  Wydane: (2012-02-01)